Travere Therapeutics' Other Non Operating Income fell 6.35% to $487,000 in Q3 2025 from the same period last year, while for Sep 2025 it was -$71,000, marking a year-over-year increase of 94.79%. This contributed to the annual value of -$3.3 million for FY2024, which is 308.16% down from last year.
As of Q3 2025, Travere Therapeutics' Other Non Operating Income stood at $487,000, which was up 192.59% from -$526,000 recorded in Q2 2025.
In the past 5 years, Travere Therapeutics' Other Non Operating Income ranged from a high of $1.4 million in Q4 2023 and a low of -$7.6 million during Q1 2022.
For the 3-year period, Travere Therapeutics' Other Non Operating Income averaged around -$110,273, with its median value being $238,000 (2024).
In the last 5 years, Travere Therapeutics' Other Non Operating Income spiked by 477.49% in 2021 and then slumped by 1,638.81% in 2024.
Over the past 5 years, Travere Therapeutics' Other Non Operating Income (Quarterly) stood at -$860,000 in 2021, then plummeted by 189.60% to -$586,000 in 2022, then soared by 157.17% to $1.4 million in 2023, then slumped by 142.29% to -$581,000 in 2024, then decreased by 6.35% to $487,000 in 2025.
Its last three reported values are $487,000 in Q3 2025, -$526,000 for Q2 2025, and $549,000 during Q1 2025.

Peer Comparison

Historic Data

Download Data 🔒

Date	Value